MGTX
MGTX
NASDAQ · Biotechnology

Meiragtx Holdings Plc

$11.59
+0.11 (+0.96%)
Financial Highlights (FY 2026)
Revenue
96.44M
Net Income
-135,321,581
Gross Margin
94.0%
Profit Margin
-140.3%
Rev Growth
+72.3%
D/E Ratio
1.08
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 94.0% 94.1% 65.8% 65.8%
Operating Margin -130.2% -117.2% -9.9% -11.8%
Profit Margin -140.3% -133.3% -10.4% -12.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 96.44M 55.98M 298.22M 353.14M
Gross Profit 90.70M 52.65M 196.30M 232.45M
Operating Income -125,561,901 -65,598,021 -29,566,882 -41,721,150
Net Income -135,321,581 -70,696,826 -30,982,952 -42,442,765
Gross Margin 94.0% 94.1% 65.8% 65.8%
Operating Margin -130.2% -117.2% -9.9% -11.8%
Profit Margin -140.3% -133.3% -10.4% -12.0%
Rev Growth +72.3% +72.3% -0.7% -1.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 272.10M 272.10M 274.26M 257.56M
Total Equity 252.07M 252.07M 356.05M 341.85M
D/E Ratio 1.08 1.08 0.77 0.75
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -125,209,869 -69,048,224 -39,492,333 -49,405,433
Free Cash Flow -35,501,473 -31,424,329